Go offline with the Player FM app!
The Implications Of China's Growing Biotech Industry With Allan Shaw
Manage episode 478199456 series 2739469
We love to hear from our listeners. Send us a message.
Business of Biotech MVP Allan Shaw is back to talk about the rise of China's biotech sector, and its evolution from fast follower to global innovation powerhouse. Increased deal activity with Chinese biopharmaceutical companies is injecting new risk into traditional development models in the West, despite an uncertain policy environment in the U.S. vis-à-vis China. Will faster trial starts, cheaper asset upfronts, and a growing talent base slingshot Shanghai's biotech hub into an innovation destination on par with Boston and San Francisco?
Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: [email protected]
Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/
Chapters
1. China's Growing Biotech Footprint (00:00:00)
2. Factors Driving Chinese Biotech Growth (00:05:03)
3. Deal Activity and Market Dynamics (00:09:07)
4. Cost Advantages and R&D Efficiency (00:14:09)
5. Clinical Trials and Regulatory Challenges (00:19:32)
6. Innovation versus Refinement (00:26:41)
7. Implications for Global Biotech (00:33:36)
8. Future of US-China Biotech Competition (00:41:02)
251 episodes
Manage episode 478199456 series 2739469
We love to hear from our listeners. Send us a message.
Business of Biotech MVP Allan Shaw is back to talk about the rise of China's biotech sector, and its evolution from fast follower to global innovation powerhouse. Increased deal activity with Chinese biopharmaceutical companies is injecting new risk into traditional development models in the West, despite an uncertain policy environment in the U.S. vis-à-vis China. Will faster trial starts, cheaper asset upfronts, and a growing talent base slingshot Shanghai's biotech hub into an innovation destination on par with Boston and San Francisco?
Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: [email protected]
Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/
Chapters
1. China's Growing Biotech Footprint (00:00:00)
2. Factors Driving Chinese Biotech Growth (00:05:03)
3. Deal Activity and Market Dynamics (00:09:07)
4. Cost Advantages and R&D Efficiency (00:14:09)
5. Clinical Trials and Regulatory Challenges (00:19:32)
6. Innovation versus Refinement (00:26:41)
7. Implications for Global Biotech (00:33:36)
8. Future of US-China Biotech Competition (00:41:02)
251 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.